Molecular Ecology Underlying Human Health and Disease: A Prototype Study

人类健康和疾病的分子生态学:原型研究

基本信息

  • 批准号:
    7544845
  • 负责人:
  • 金额:
    $ 4.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-15 至 2010-09-14
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Project Summary: Despite making up approximately 90 percent of the cells in the human body, the contributions of human-associated microbes to overall human health remain largely unknown. Researchers are now beginning to study the complex interactions between these microbes and their human hosts. Technological advances coupled with an increased interest in this new frontier in health-related research, including the creation of the Human Microbiome Project, has already yielded interesting insight into diverse biological processes. In this application, I will describe a plan to probe the human microbiome for genetic elements that have implication for human health. As a proof of principle, I will describe a set of experiments to identify antibiotic resistance elements present in a community of soil bacteria. I will then use this data to identify homologous resistance elements within the human microbiome. In addition to enriching our knowledge of the genetic determinants of antibiotic resistance, this work will serve as a model for the application of metagenomic technology to the assessment of human health. Public Health Relevance: The bacteria that live in the human gut and mouth are major determinants in the health of a person. Studying the biochemical properties of these bacteria will give insight into human disease. In this work, I plan to use a new approach to identify genes within the human-associated bacterial community that confer antibiotic resistance. The methodology outlined in this application will serve as a guide for the diagnosis and treatment of other diseases linked to the bacteria present within people.
项目概述:尽管人类相关微生物占人体细胞的90%,但其对人类整体健康的贡献在很大程度上仍是未知的。研究人员现在开始研究这些微生物与其人类宿主之间的复杂相互作用。技术进步加上对这一与健康有关的研究新领域的兴趣增加,包括人类微生物组项目的创建,已经对不同的生物过程产生了有趣的见解。在本申请中,我将描述一项计划,以探测人类微生物组中对人类健康有影响的遗传因素。作为原理的证明,我将描述一组实验,以确定土壤细菌群落中存在的抗生素耐药性元素。然后,我将使用这些数据来识别人类微生物组中的同源抗性元件。除了丰富我们对抗生素耐药性的遗传决定因素的知识外,这项工作还将作为宏基因组技术应用于人类健康评估的模型。公共卫生相关性:生活在人类肠道和口腔中的细菌是一个人健康的主要决定因素。研究这些细菌的生化特性将有助于深入了解人类疾病。在这项工作中,我计划使用一种新的方法来识别人类相关细菌群落中赋予抗生素抗性的基因。本申请中概述的方法将作为诊断和治疗与人体内存在的细菌相关的其他疾病的指南。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Justin Joseph Donato其他文献

Justin Joseph Donato的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Justin Joseph Donato', 18)}}的其他基金

Molecular Ecology Underlying Human Health and Disease: A Prototype Study
人类健康和疾病的分子生态学:原型研究
  • 批准号:
    7692270
  • 财政年份:
    2008
  • 资助金额:
    $ 4.96万
  • 项目类别:

相似海外基金

Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
  • 批准号:
    10653587
  • 财政年份:
    2023
  • 资助金额:
    $ 4.96万
  • 项目类别:
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    10585038
  • 财政年份:
    2023
  • 资助金额:
    $ 4.96万
  • 项目类别:
Creation of Next-generation Aminoglycoside Antibiotics Active against Multidrug-resistant Gram-negative Bacteria
开发对多重耐药革兰氏阴性菌具有活性的下一代氨基糖苷类抗生素
  • 批准号:
    20K06982
  • 财政年份:
    2020
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug- Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    9934590
  • 财政年份:
    2019
  • 资助金额:
    $ 4.96万
  • 项目类别:
Combating Antibiotic Resistance to Aminoglycoside Antibiotics through Chemical Synthesis
通过化学合成对抗氨基糖苷类抗生素的耐药性
  • 批准号:
    392481159
  • 财政年份:
    2017
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Research Fellowships
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    9082038
  • 财政年份:
    2016
  • 资助金额:
    $ 4.96万
  • 项目类别:
Functional analysis of radical SAM enzymes involved in the biosynthesis of aminoglycoside antibiotics
氨基糖苷类抗生素生物合成中自由基SAM酶的功能分析
  • 批准号:
    26410174
  • 财政年份:
    2014
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EAPSI:Synthesis of Aminoglycoside Antibiotics
EAPSI:氨基糖苷类抗生素的合成
  • 批准号:
    1106886
  • 财政年份:
    2011
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Fellowship Award
Preclinical evaluation of aminoglycoside antibiotics-derived amphiphiles (AADAs)
氨基糖苷类抗生素衍生的两亲物 (AADA) 的临床前评估
  • 批准号:
    185482
  • 财政年份:
    2009
  • 资助金额:
    $ 4.96万
  • 项目类别:
    Operating Grants
AMINOGLYCOSIDE ANTIBIOTICS FOR CYSTIC FIBROSIS
治疗囊性纤维化的氨基糖苷类抗生素
  • 批准号:
    6565399
  • 财政年份:
    2001
  • 资助金额:
    $ 4.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了